A Post Marketing Surveillance to Evaluate the Safety and Efficacy of Brilinta

CompletedOBSERVATIONAL
Enrollment

3,402

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

July 20, 2016

Study Completion Date

July 20, 2016

Conditions
Acute Coronary Syndromes
Trial Locations (23)

Unknown

Research Site, Cheonan-si

Research Site, Chuncheon

Research Site, Wŏnju

Research Site, Ansan-si

Research Site, Anyang-si

Research Site, Bucheon-si

Research Site, Goyang-si

Research Site, Koyang-shi

Research Site, Seongnam-si

Research Site, Suwon

Research Site, Andong

Research Site, Gumi

Research Site, Gimhae

Research Site, Iksan-si

Research Site, Jeonju

Research Site, Suncheon-si

Research Site, Busan

Research Site, Daegu

Research Site, Daejeon

Research Site, Gwangju

Research Site, Incheon

Research Site, Seoul

Research Site, Ulsan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY